• Type: Other
    • Resolution: Answered
    • Priority: High
    • Component/s: None
    • None
    • Kelcey Richard
    • 937-631-3817
    • Straith Hospital for Special Surgery
    • Hide
      Thank you for your inquiry regarding CMS506v6, Safe Use of Opioids - Concurrent Prescribing. Skilled nursing facilities (SNFs) and rehab facilities are not included in the "Discharge to Acute Care Facility" value set (OID 2.16.840.1.113883.3.117.1.7.1.87) and should not be excluded from the measure denominator.


      Thank you for your inquiry regarding CMS108v12, Venous Thromboembolism Prophylaxis. Below are the qualifying VTE prophylaxis medication value sets. Please visit the VSAC website https://vsac.nlm.nih.gov/welcome to find the medications included in each value set.

      ( ["Medication, Administered": "Low Dose Unfractionated Heparin for VTE Prophylaxis"] VTEMedication

          where VTEMedication.route in "Subcutaneous route"

      )

        union ["Medication, Administered": "Low Molecular Weight Heparin for VTE Prophylaxis"]

        union ["Medication, Administered": "Injectable Factor Xa Inhibitor for VTE Prophylaxis"]

        union ["Medication, Administered": "Warfarin"]

        union ["Medication, Administered": "Rivaroxaban for VTE Prophylaxis"]

       

      Please note that patients given Apixaban or Edoxaban listed in the value set “Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment” would be counted in numerator population only when they also have either a prior or present diagnosis of atrial fibrillation or prior diagnosis of VTE Or prior or present hip/knee replacement.

      If pharmacological prophylaxis is not given due to a medical reason, then a medical reason for not administering VTE prophylaxis ( for both pharmacological and Mechanical) must be explicitly documented by MD/APN/PA or pharmacist within the qualifying timeframe for measurement to meet VTE-1. An order for SCD alone will not satisfy the numerator condition.


      Thank you for your inquiry regarding CMS819v2, Hospital Harm - Opioid-Related Adverse Events. The initial population includes inpatient hospitalizations that end during the measurement period for patients age 18 and older and at least one opioid medication administration starts during the hospitalization outside of the operating room. This initial population applies to all inpatient hospitalization not just inpatient surgery patients.
      Show
      Thank you for your inquiry regarding CMS506v6, Safe Use of Opioids - Concurrent Prescribing. Skilled nursing facilities (SNFs) and rehab facilities are not included in the "Discharge to Acute Care Facility" value set (OID 2.16.840.1.113883.3.117.1.7.1.87) and should not be excluded from the measure denominator. Thank you for your inquiry regarding CMS108v12, Venous Thromboembolism Prophylaxis. Below are the qualifying VTE prophylaxis medication value sets. Please visit the VSAC website https://vsac.nlm.nih.gov/welcome to find the medications included in each value set. ( ["Medication, Administered": "Low Dose Unfractionated Heparin for VTE Prophylaxis"] VTEMedication     where VTEMedication.route in "Subcutaneous route" )   union ["Medication, Administered": "Low Molecular Weight Heparin for VTE Prophylaxis"]   union ["Medication, Administered": "Injectable Factor Xa Inhibitor for VTE Prophylaxis"]   union ["Medication, Administered": "Warfarin"]   union ["Medication, Administered": "Rivaroxaban for VTE Prophylaxis"]   Please note that patients given Apixaban or Edoxaban listed in the value set “Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment” would be counted in numerator population only when they also have either a prior or present diagnosis of atrial fibrillation or prior diagnosis of VTE Or prior or present hip/knee replacement. If pharmacological prophylaxis is not given due to a medical reason, then a medical reason for not administering VTE prophylaxis ( for both pharmacological and Mechanical) must be explicitly documented by MD/APN/PA or pharmacist within the qualifying timeframe for measurement to meet VTE-1. An order for SCD alone will not satisfy the numerator condition. Thank you for your inquiry regarding CMS819v2, Hospital Harm - Opioid-Related Adverse Events. The initial population includes inpatient hospitalizations that end during the measurement period for patients age 18 and older and at least one opioid medication administration starts during the hospitalization outside of the operating room. This initial population applies to all inpatient hospitalization not just inpatient surgery patients.
    • CMS0108v12
    • Verifying correct data populations

      1. Safe Use of Opioids - Concurrent Prescribing CMS eCQM ID CMS506v6

      Is a skilled nursing facility or subacute rehab considered part of the denominator exclusion for " patients discharged to another inpatient care facility" or only patients transferred to another acute care hospital?

      2. Venous Thromboembolism Prophylaxis- CMS eCQM ID CMS108v12

      Is there a list of included "VTE prophylaxis" medications that would satisfy this measure? In particular- is Heparin, Enoxaparin, Apixaban, Clopidogrel, Aspirin 81mg twice daily OR Aspirin 325 once daily, and Warfarin included? Does provider documentation of a contraindication to medication prophylaxis and an order for sequential compression devices (SCD) qualify instead?

      3. Hospital Harm - Opioid-Related Adverse Events CMS eCQM ID CMS819v2

      Are all inpatients included in this measure or just inpatient surgery patients? I am not sure if this is relevant to our patient population as all of our surgery patients are outpatient only, However, we have non-surgical inpatient patients who receive opioids.

        1. ~WRD1638.jpg
          ~WRD1638.jpg
          0.8 kB
        2. image001.png
          image001.png
          10 kB
        3. image001.png
          image001.png
          10 kB
        4. image005.jpg
          image005.jpg
          0.8 kB

            Assignee:
            Augustine Weber
            Reporter:
            Kelcey Richard (Inactive)
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: